📖
Prevalence and impact of Thiopurine S-methyltransferase (TPMT) and Nudix hydrolase 15 (NUDT15) polymorphisms on the occurrence of myelosuppression in Thai patients with inflammatory bowel disease receiving thiopurine therapy.
Phoojaroenchanachai R, Chaemsupaphan T, Sattayalertyanyong O, Subdee N, Phaophu P, Salaemae M, Limsrivilai J

Prevalence and impact of Thiopurine S-methyltransferase (TPMT) and Nudix hydrolase 15 (NUDT15) polymorphisms on the occurrence of myelosuppression in Thai patients with inflammatory bowel disease receiving thiopurine therapy.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Crohns Colitis 360.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Prevalence and impact of Thiopurine S-methyltransferase (TPMT) and Nudix hydrolase 15 (NUDT15) polymorphisms on the occurrence of myelosuppression in Thai patients with inflammatory bowel disease receiving thiopurine therapy.
Author / Organization Phoojaroenchanachai R, Chaemsupaphan T, Sattayalertyanyong O, Subdee N, Phaophu P, Salaemae M, Limsrivilai J
Subject & Discipline Crohns Colitis 360
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-8243
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »